Successful Treatment of Facial Pseudolymphoma With Intravenous Rituximab: A Case Report

ABSTRACT Intravenous rituximab demonstrated significant efficacy in treating a case of refractory cutaneous pseudolymphoma that failed multiple conventional therapies, including corticosteroids, hydroxychloroquine, methotrexate, and biologics. The patient, a 42‐year‐old man, initially developed eryt...

Full description

Bibliographic Details

Published in:	Clinical Case Reports
Main Authors:	Elham Behrangi, Nastaran Khodakarim, Shila Amiri, Seyyedeh Tahereh Rahimi, Neda Safarzadeh, Alireza Jafarzadeh
Format:	Article
Language:	English
Published:	Wiley 2025-10-01
Subjects:	B‐cell pseudolymphoma CD20 cutaneous pseudolymphoma histopathology immunohistochemistry immunotherapy
Online Access:	https://doi.org/10.1002/ccr3.71101